Paclitaxel plus ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors

Journal of Clinical Oncology

Volumn 25, Issue 1, 2007, Pages 85-90

  Kondagunta, G Varuni ^a   Bacik, Jennifer ^a   Sheinfeld, Joel ^a   Bajorin, Dean ^a   Bains, Manjit ^a   Reich, Lillian ^a   Deluca, John ^a   Budnick, Amy ^a   Ishill, Nicole ^a   Mazumdar, Madhu ^a   Bosl, George J ^a   Motzer, Robert J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; MESNA; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GERM CELL TUMOR; HEARING DISORDER; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; TREATMENT RESPONSE; METASTASIS; MIDDLE AGED; NEOPLASM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PACLITAXEL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 34548405549     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.9401     Document Type: Article

References (16)

1. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. N Engl J Med 337:242-253, 1997
2. Broun ER, Nichols CR, Kneebone P, et al: Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117:124-128, 1992
3. Motzer RJ: High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan-Kettering Cancer Center. Bone Marrow Transplant 18:S53-S54, 1996 (suppl 1)
4. Linkesch W, Greinix HT, Hocker P, et al: Longterm follow up of phase I/II trial of ultra-high carboplatin, VP-16, cyclophosphamide with ABMT in refractory or relapsed NSGCT. Proc Am Soc Clin Oncol 12:232, 1993 (abstr)
5. Siegert W, Beyer J, Strohscheer I, et al: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study - The German Testicular Cancer Cooperative Study Group. J Clin Oncol 12:1223-1231, 1994
6. Motzer RJ, Geller NL, Tan CC, et al: Salvage chemotherapy for patients with germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 67:1305-1310, 1991
7. Motzer RJ, Mazumdar M, Sheinfeld J, et al: Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18:1173-1180, 2000
8. Calvert AH, Newell DR, Gumbrell LA, et al: Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748-1756, 1989
9. Fawdry RM, Gruenewald SM: Three-hour volume of distribution method: An accurate simplified method of glomerular filtration rate measurement. J Nucl Med 28:510-513, 1987
10. Mazumdar M, Smith A, Tong WP, et al: Calvert's formula for dosing carboplatin: Overview and concerns of applicability in high-dose setting. J Natl Cancer Inst 92:1434-1436, 2000
11. Jelliffe RW: Letter: Creatinine clearance - Bedside estimate. Ann Intern Med 79:604-605, 1973
12. Motzer RJ, Bosl GJ: High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions. J Natl Cancer Inst 84:1703-1709, 1992
13. Saxman SB, Nichols CR, Einhorn LH: Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 12:1390-1393, 1994
14. Vuky J, Bains M, Bacik J, et al: Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. J Clin Oncol 19:682-688, 2001
15. Kondagunta GV, Bacik J, Donadio A, et al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005
16. Dubs A, Jacky E, Stahel R, et al: Ototoxicity in patients with dose-intensive therapy for cisplatin-resistant germ cell tumors. J Clin Oncol 22:1158, 2004